This is the second of a three-part series of reports that explore strategic models for growth in Asia Pacific.  The first in the series, "Affordable therapies: Gaining a competitive advantage in Asia Pacific,” examined the strategy of developing lower-cost medicines to serve a huge unmet need. 

"Innovation the Asia way: Moving at 'Asia speed' with world-class quality" focuses on local companies developing innovative medicines – those that will compete with new medicines coming from Western biopharma.

The third and final report will address "going global" – what local companies should do if their strategy is to become a global player.